State Street Corp Arca Biopharma, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$1.58 - $1.78 $18,059 - $20,345
-11,430 Reduced 16.07%
59,707 $105,000
Q3 2023

Nov 14, 2023
SELL
$2.01 - $2.07 $1,004 - $1,035
-500 Reduced 0.7%
71,137 $142,000
Q2 2022

Aug 15, 2022
BUY
$2.2 - $2.53 $3,740 - $4,301
1,700 Added 2.43%
71,637 $178,000
Q3 2021

Nov 15, 2021
BUY
$2.77 - $3.74 $2,493 - $3,366
900 Added 1.3%
69,937 $207,000
Q2 2021

Aug 16, 2021
BUY
$3.06 - $3.9 $211,253 - $269,244
69,037 New
69,037 $241,000

Others Institutions Holding ABIO

# of Institutions
2
Shares Held
280K
Call Options Held
0
Put Options Held
0
View Full List

About ARCA biopharma, Inc.

ABIO Quotes by TradingView
  • Ticker ABIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,410,100
  • Description
  • ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...
More about ABIO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email